Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.45    0.00 (0.00%)
Bid:
8.30
Ask:
8.60
Spread: 0.30 (3.614%)
Market Cap: £18.43m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

Annual Information Update

7 Feb 2011 12:18

RNS Number : 7974A
Phytopharm PLC
07 February 2011
 

Phytopharm plc

 

Annual Information Update

 

Phytopharm plc (the Company) announces that, in accordance with the requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, and following publication of the Annual Report on 31 January 2011, the following information has been published or made available to the public between 14 December 2009 and 7 February 2011 inclusive, in compliance with laws and rules dealing with the regulation of securities, issuers of securities and securities markets.

1. Announcements made via the Regulatory Information Service ("RIS")

All the announcements listed below were published through a regulatory information service on the dates indicated. Copies can be obtained from the London Stock Exchange website, http://www.londonstockexchange.com or from the Company's website www.phytopharm.com

Date of publication

Title

1 February 2011

Total voting rights

1 February 2011

Annual Report 2010 and notice of 2011 AGM

19 January 2011

Director/PDMR shareholding

19 January 2011

Director/PDMR shareholding

14 January 2011

Holdings in Company

10 January 2011

Holdings in Company

7 January 2011

Block Listing Application

4 January 2011

Total voting rights

21 December 2010

Director/PDMR shareholding

21 December 2010

Director/PDMR shareholding

14 December 2010

Block Listing application

30 November 2010

Final results

17 November 2010

Research update

3 November 2010

Block listing interim review

1 November 2010

Preliminary results - change of date

1 November 2010

Notice of preliminary results

29 September 2010

Presentation at scientific conference

18 August 2010

Interim management statement

22 July 2010

Director/PDMR shareholding

22 July 2010

Director/PDMR shareholding

5 July 2010

Change of registered office

21 June 2010

Appointment of Chief Executive Officer

14 June 2010

Regulatory approval to begin Cogane™ Phase II trial

24 May 2010

Half yearly report

19 May 2010

Notice of results

4 May 2010

Block listing interim review

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

31 March 2010

Results of Annual General Meeting

2 March 2010

Notice of Annual General Meeting

11 February 2010

Interim Management Statement

15 January 2010

Appointment of R & D Director

5 January 2010

Holding in company

4 January 2010

Total voting rights

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

29 December 2009

GM results

22 December 2009

Open Offer results

15 December 2009

Correction to Form of Proxy

15 December 2009

Annual Information update

14 December 2009

Presents data at XVIII WFN Congress

2. Documents published or sent to Shareholders, filed with the UK Listing Authority or submitted to the FSA including those filed with the National Storage Mechanism:

Date of publication

Title

1 February 2011

Notice of 2011 Annual General Meeting

1 February 2011

Annual Report 2010

2 June 2010

Interim Report 2010

31 March 2010

AGM resolutions

2 March2010

Notice of Annual General Meeting

30 December 2009

General Meeting resolutions

The 2010 Interim and 2010 Annual reports are available on the Company's website www.phytopharm.com

3. Documents filed at Companies House

The following documents were files at Companies House. Copies of these documents can be obtained from the Companies House website at www.companieshouse.gov.uk, or Companies House, Crown Way, Cardiff CF14 3UZ

Date of Publication

Title

25 January 2011

Form SH01 Return of allotment of shares on 14 January 2011

5 January 2011

Form SH01 Return of allotment of shares on 16 December 2010

16 December 2010

Form AR01 Annual return

6 July 2010

Form AP01 Appointment of director

6 July 2010

Form AD01 change of registered office address

31 March 2010

Articles of Association approved by shareholders on 30 march 2010

31 March 2010

Annual General Meeting resolutions

25 January 2010

Form AP01 Appointment of director

4 January 2010

Form SH01 Return of allotment of shares on 29 December 2009

Copies of all documents referred to above are also available for inspection at the Company's registered office (Lakeview House, 2 Lakeview Court, Ermine Business Park, Huntingdon, Cambs PE29 6UA, United Kingdom) during normal business hours or by written request from the Company Secretary.

This annual information is required by, and is being made pursuant to, Article 10 of the Prospectus Directive as implemented by the UK Prospectus Rule 5.2 and not for any other purpose and neither the Company, nor any other person, takes any responsibility for, or makes any representation, express of implied, as to the accuracy or completeness of, the information which it contains. The information is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Neither this annual information update, not referred to in it, constitutes, by virtue of this communication, an offer of securities addressed to any person and it should not be relied on by any person.

For further information, please contact:

Zoe McGowan, Company Secretary

Phytopharm plc Tel No: +44 (0)1480 437697

Further information about Phytopharm can be found on the Company's website www.phytopharm.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUEAAAXEFAFEFF
Date   Source Headline
20th Jun 20077:00 amRNSBoard Change
14th Jun 20073:02 pmRNSResult of EGM
11th Jun 200711:56 amRNSHolding(s) in Company
7th Jun 200712:13 pmRNSDirector/PDMR Shareholding
5th Jun 20077:02 amRNSResearch Update
22nd May 20079:41 amRNSNotice of EGM
17th May 20077:01 amRNSResearch Update
9th May 20072:49 pmRNSDirector/PDMR Shareholding
9th May 20072:49 pmRNSDirector/PDMR Shareholding
9th May 20072:43 pmRNSDirector/PDMR Shareholding
9th May 20072:40 pmRNSDirector/PDMR Shareholding
1st May 20071:36 pmRNSBlocklisting Interim Review
1st May 20077:02 amRNSInterim Results
24th Apr 20074:37 pmRNSPrice Monitoring Extension
20th Apr 200711:26 amRNSNotice of Results
16th Apr 20077:01 amRNSProduct Launch
2nd Apr 20077:01 amRNSTotal Voting Rights
29th Mar 20079:36 amRNSResult of AGM
26th Mar 20077:12 amRNSProduct Launch
19th Mar 200711:45 amRNSBlocklisting Interim Review
7th Mar 20073:15 pmRNSHolding(s) in Company
7th Mar 20072:50 pmRNSHolding(s) in Company
2nd Mar 20072:25 pmRNSAGM Notification
1st Mar 20074:41 pmRNSSecond Price Monitoring Extn
1st Mar 20074:39 pmRNSPrice Monitoring Extension
1st Mar 20073:37 pmRNSPlacing
15th Jan 20074:36 pmRNSPrice Monitoring Extension
15th Jan 200712:52 pmRNSAnnual Information Update
10th Jan 20073:32 pmRNSDirector/PDMR Shareholding
10th Jan 20073:31 pmRNSDirector/PDMR Shareholding
9th Jan 200710:15 amRNSBoard Changes
19th Dec 200612:43 pmRNSTotal Voting Rights
10th Nov 20061:03 pmRNSDirector/PDMR Shareholding
8th Nov 20067:01 amRNSFinal Results
1st Nov 200612:58 pmRNSBlocklisting Interim Review
27th Oct 20063:02 pmRNSNotice of Results
18th Sep 20062:36 pmRNSBlocklisting Interim Review
5th Sep 20067:01 amRNSBoard Changes
21st Jul 20067:00 amRNSBoard Appointment
5th Jun 20067:00 amRNSAppointment of Non-Exec
19th May 20069:38 amRNSHolding(s) in Company
11th May 200610:37 amRNSDirector/PDMR Shareholding
11th May 200610:35 amRNSDirector/PDMR Shareholding
8th May 20067:02 amRNSInterim Results
3rd May 200612:32 pmRNSBlocklisting Interim Review
27th Apr 200611:33 amRNSHolding(s) in Company
27th Apr 200611:22 amRNSHolding(s) in Company
26th Apr 20067:01 amRNSAdvisor Appointment
24th Apr 20067:01 amRNSProduct Launch
10th Apr 20067:01 amRNSResearch Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.